At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BGLC BioNexus Gene Lab Corp.
Market Closed 05-31 16:00:00 EDT
0.4248
-0.0108
-2.48%
盘后0.4459
+0.0211+4.97%
18:04 EDT
High0.4499
Low0.4245
Vol67.53K
Open0.4499
D1 Closing0.4356
Amplitude5.83%
Mkt Cap7.51M
Tradable Cap4.23M
Total Shares17.67M
T/O29.24K
T/O Rate0.68%
Tradable Shares9.96M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Bionexus Gene Lab Says Got Notice From Nasdaq That Co Is Eligible For Additional 180 Calendar Day Extension Period, Or Until Nov 4 To Regain Compliance
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.